Ferring is a vibrant, innovative, research-driven biopharmaceutical company with an uncompromising philosophy:

People come first at Ferring.

at Ferring, we define ourselves with a single word.

Learn more

the health of people comes first

We research, develop, manufacture and market products that work on the body’s own terms to help health care providers combat a wide range of diseases and medical conditions.

Learn More About Ferring Products >

  • @FerringUSA on Twitter

    Check out the "7 things you need to know for #CdiffAwarenessMonth" via @Healio bit.ly/2Jhuv1N #Cdiff
  • Public Policy Statement:

    Proposed Legislation to Improve Price Transparency and Better Serve the Patient, the Taxpayer and the Physician.

    Read the full statement >

  • Latest News

    Parsippany, NJ – October 1, 2019 – Ferring Pharmaceuticals Inc. today published a manuscript in the Journal of Managed Care & Specialty Pharmacy demonstrating that nocturia, defined as waking up ≥2 times for nighttime urination1 (in this study), is associated with a substantial impact to the U.S. economy.

    Find out what’s new at Ferring Pharmaceuticals.
    View More Press Releases >

  • passionate people come first to Ferring

    What kind of people succeed at Ferring? People who are smart. Curious. Ambitious. People who want to do well. And do good.

    Carers. Sharers. Darers.

    Learn More About Ferring Careers >


our people come first to help

We’re a global company. With a local orientation. We do things with and for our neighbors. Because we’re part of their community and they’re part of ours.


Learn More About Ferring Community Involvement >

This site contains material about Ferring Pharmaceuticals Inc. (hereinafter "Ferring") and its various products that may be of interest to Ferring's employees and customers, as well as to members of the health care community and the general public. Please feel free to browse this web site. Your access and use of the information contained herein is subject to the following terms and conditions and all applicable laws. By accessing and browsing this web site, you accept, without limitation or qualification, these terms and conditions and acknowledge that they supersede any other agreement between you and Ferring.

All information on this site is intended for US audiences only.

CERVIDIL, CLENPIQ, ENDOMETRIN, EUFLEXXA, FIRMAGON, MENOPUR, NOCDURNA, NOVAREL, and ZOMACTON are registered trademarks of Ferring B.V. INVOCELL is a registered trademark of INVO BioScience.

©2008-2019 Ferring Pharmaceuticals.  US--1900006